4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Boundless Bio, Inc. (BOLD) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 28 employees. Its market capitalization is roughly $55 million. In the fiscal year ended 2025-12-31, BOLD reported $0M in revenue and ($58M) in net income.
Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($64M) | ($73M) | ($55M) | ($46M) |
| Net Income | ($58M) | ($65M) | ($49M) | ($46M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($14M) | ($14M) | ($15M) | ($17M) | ($17M) | — |
| Net Income | ($14M) | ($13M) | ($14M) | ($16M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $157M | $206M | $130M | $77M | — |
| Total Liabilities | $58M | $56M | $257M | $158M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BOLD viewer.
About TickerBase · Data methodology & sources